top of page

The True Source of COVID-19

The Effects of COVID-19

NA of SEM.png

  1. Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity (2021)

  2. Innovations in Pharmaceutical Manufacturing on the Horizon: Technical Challenges, Regulatory Issues, and Recommendations (2021)

  3. Rapid Expert Consultations on the COVID-19 Pandemic: March 14, 2020-April 8, 2020

  4. Rental Eviction and the COVID-19 Pandemic: Averting a Looming Crisis (2021)

  5. Addressing Disaster Vulnerability among Homeless Populations during COVID-19 (2021)

  6. School-Based Strategies for Addressing the Mental Health and Well-Being of Youth in the Wake of COVID-19 (2021)

  7. COVID-19 and the Present and Future of Black Communities: The Role of Black Physicians, Engineers, and Scientists: Proceedings of a Workshop (2021)

  8. Short-Term Strategies for Addressing the Impacts of the COVID-19 Pandemic on Women's Workforce Participation (2021)

  9. The Impact of COVID-19 on the Careers of Women in Academic Sciences, Engineering, and Medicine (2021)

  10. Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned: Proceedings of a Workshop–in Brief (2021)

  11. Learning from Rapid Response, Innovation, and Adaptation to the COVID-19 Crisis: Proceedings of a Workshop–in Brief (2021)

   

CDC.jpg

  1.  Find maps and charts tracking cases, deaths, and trends of COVID-19 in the United States, updated daily by 8 pm ET

  2.  Vaccination Delivery and Administration - Track the progress of COVID-19 vaccination across the United States.

        a.  COVID-19 Vaccinations in the United States

        b.  Percent of People Receiving COVID - 19 Vaccine by Race/Ethnicity and Date Reported to CDC, United States

        c.   Vaccination Equity | Maps, charts, and data provided by CDC, updates daily by 8 pm ET

        d.  Vaccination and Case Trends of COVID-19 in the United States

        e.  Vaccination Coverage and Other Outcomes

        f.   Percent of Pregnant People aged 18-49 years receiving at least one dose of a COVID-19 vaccine during pregnancy overall, by           

             race/ethnicity, and date reported to CDC - Vaccine Safety Datalink*, United States

        g.  COVID-19 Vaccination among People with Disabilities

        h.  Global COVID-19 Vaccinations

   3.  Case, Death, & Laboratory Testing Trends by Location and Demographics

        a.  COVID-19 Weekly Cases and Deaths per 100,000 Population by Age, Race/Ethnicity, and Sex

        b.  United States COVID-19 Cases, Deaths, and Laboratory Testing (NAATs) by State, Territory, and Jurisdiction

        c.  Trends in Number of COVID-19 Cases and Deaths in the US Reported to CDC, by State/Territory

        d.  Demographic Trends of COVID-19 cases and deaths in the US reported to CDC

        e.  Trends in COVID-19 Cases and Deaths in the United States, by County-level Population Factors

        f.   Global Cumulative Cases of COVID - 19 Reported Per 100,000 Population

   4.  Follow the Burden of COVID-19 among Healthcare Personnel and across Multiple Health Care Settings

        a.  About Health Care Setting Data

        b.  New Admissions with Confirmed Cases of COVID - 19 Per 100,000 Population by Age Group, United States

        c.  United States Trends in Emergency Department (ED) Visits

        d.  Prevalent Hospitalizations of Patients with Confirmed COVID - 19, United States

        e.  COVID-19 Hospitalizations and Disease Severity

        f.   COVID-NET Laboratory-confirmed COVID-19 hospitalizations

        g.  Confirmed COVID-19 Cases and Deaths among Staff and Rate per 1,000 Resident-Weeks in Nursing Homes, by Week - United States

        h.  Confirmed COVID-19 Cases and Deaths among Residents and Rate per 1,000 Resident-Weeks in Nursing Homes, by Week - U.S.

        i.   Cases & Deaths among Healthcare Personnel

   5.  Genomic Surveillance

        a.  Variant Proportions in the United States

        b.  Published SARS-CoV-2 Sequences

        c.  Global Variants Report

   6.  Learn more about COVID-19 Seroprevalence Surveys, which are used to determine how much of the U.S. population has been infected 

        with SARS-COV-2, the virus that causes COVID-19

        a.  Nationwide Commercial Laboratory Seroprevalence Survey

        b.  Commercial Laboratory Seroprevalence Survey Data

        c.  Nationwide Blood Donor Seroprevalence Survey

   7.  People Who Are at Increased Risk

        a.  Underlying Medical Conditions

        b.  Data on COVID-19 during Pregnancy: Severity of Maternal Illness

        c.  Confirmed COVID - 19 Cases and Deaths in U.S. Correctional and Detention Facilities by State

   8.  Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States

        a.  Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States

   9.   Explore the social impacts of COVID-19 & see how human movement & COVID-19 prevention measures correspond to trends in the

         pandemic

        a.  State-Issued Prevention Measures at the State-Level

        b.  Explore Human Mobility and COVID - 19 Transmission in your Local Area

        c.  Social Impact COVID-19 Events in the United States

bottom of page